Amid worries regarding insulin availability, Novo Pakistan is increasing its efforts to aid individuals managing diabetes. The firm is collaborating closely with associates to maintain treatment continuity, acknowledging the vital importance of reliable insulin access for patients and their relatives.
An estimated 33 million individuals live with diabetes in Pakistan, with upwards of one million depending on insulin. Acknowledging this obstacle, Novo Pakistan works toward practical, enduring answers to tackle the national diabetes crisis.
Mehtaz Sultan Khan, General Manager of Novo Pakistan, stated: “Diabetes care has been at the heart of Novo for more than 100 years and delivering on that commitment remains our priority today. For people who depend on insulin, reliable access to treatment is essential. We recognise the concerns being raised and are stepping up to play our part in supporting patients in Pakistan.”
As the nation addresses its rising diabetes challenge, Novo maintains its dedication to cooperating with medical experts, government officials, and patient groups to enhance treatment. Individuals worried about their insulin prescriptions should consult a medical professional regarding proper actions. Patients may also use educational materials, advice, and medical contacts via NovoCare. Support and information are available at NovoCare.pk or by calling 021-1111-46686.
